FDA — authorised 16 November 2017
- Marketing authorisation holder: GENENTECH INC
- Status: approved
FDA authorised Hemlibra on 16 November 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 November 2017.
GENENTECH INC holds the US marketing authorisation.